Biotechnology company specialising in biomedical research in the field of neuropathic pain. It assesses the efficacy of drugs in the developmental phase in the international pharmaceutical industry using a specific screening method of experimental models, for drugs in initial development phases, and clinical models, for advanced phases. Within its own research it identifies new therapeutic targets and it is developing a new program of drug dicovery The company was created in 2005 and received the CIDEM Genesis grant and the 2006 Prize for Business Excellence awarded by the Círculo de Mujeres de Negocios (a Spanish association of businesswomen), a NEOTEC grant from CDTI and a Capital Concept grant from CIDEM Its future projects include plans to set up a pain research centre.
Contact us